Axio BioPharma is a biotechnology and biomanufacturing company that provides biologics development for biopharmaceutical production.
Axio BioPharma has raised $2.4M in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2026.
Axio BioPharma's investors include Chisos Capital, Plug and Play, Chemical Angel Network, Elmsted Partners LLC, Forward BIOLABS.
Axio BioPharma is headquartered in Madison, United States.
Axio BioPharma is a biotechnology and biomanufacturing company that provides biologics development for biopharmaceutical production.
Axio BioPharma is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Axio BioPharma — Funding & Investors." VCBacked, September 21, 2026, https://www.vcbacked.co/company/axio-biopharma. Accessed October 31, 2026.
VCBacked. (2026). Axio BioPharma — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/axio-biopharma
{{cite web |title=Axio BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/axio-biopharma |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated